These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12519102)
1. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Hummel B; Walden J; Stampfer R; Dittmann S; Amann B; Sterr A; Schaefer M; Frye MA; Grunze H Bipolar Disord; 2002 Dec; 4(6):412-7. PubMed ID: 12519102 [TBL] [Abstract][Full Text] [Related]
2. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842 [TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. Kakkar AK; Rehan HS; Unni KE; Gupta NK; Chopra D; Kataria D Eur Psychiatry; 2009 Apr; 24(3):178-82. PubMed ID: 19324530 [TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine in bipolar disorder: a critical review of the literature. Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S Expert Opin Pharmacother; 2007 Apr; 8(5):649-56. PubMed ID: 17376019 [TBL] [Abstract][Full Text] [Related]
6. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages. Misdrahi D; Tournier M; Droulout T; Grolleau A; Titier K; Molimard M; Verdoux H Eur Psychiatry; 2008 Sep; 23(6):409-12. PubMed ID: 18755575 [TBL] [Abstract][Full Text] [Related]
7. [Oxcarbazepine in the treatment of affective and schizoaffective disorders]. Dietrich DE; Kropp S; Emrich HM Fortschr Neurol Psychiatr; 2003 May; 71(5):255-64. PubMed ID: 12740757 [TBL] [Abstract][Full Text] [Related]
8. An open-label trial of adjunctive oxcarbazepine for bipolar disorder. Conway CR; Chibnall JT; Nelson LA; McGuire JM; Abraham PF; Baram VY; Grossberg GT; Carroll BJ J Clin Psychopharmacol; 2006 Feb; 26(1):95-7. PubMed ID: 16415718 [No Abstract] [Full Text] [Related]
13. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder. Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731 [TBL] [Abstract][Full Text] [Related]
14. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design. Grunze HC; Normann C; Langosch J; Schaefer M; Amann B; Sterr A; Schloesser S; Kleindienst N; Walden J J Clin Psychiatry; 2001 Jun; 62(6):464-8. PubMed ID: 11465524 [TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders. Raja M; Azzoni A Int J Neuropsychopharmacol; 2003 Dec; 6(4):409-14. PubMed ID: 14604456 [TBL] [Abstract][Full Text] [Related]
16. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Hirschfeld RM; Kasper S Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610 [TBL] [Abstract][Full Text] [Related]
17. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246 [TBL] [Abstract][Full Text] [Related]